US Patent 11261446 Compounds and methods for modulating UBE3A-ATS
Patent 11261446 was granted and assigned to Ionis Pharmaceuticals on March, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
April 21, 2021
0
Date of Patent
March 1, 2022
0
Patent Applicant
Patent Application Number
17236671
0
Patent Citations Received
Patent Inventor Names
Paymaan Jafar-nejad
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11261446 Compounds and methods for modulating UBE3A-ATS
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
